• 1. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 2. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 3. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 4. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 5. Enantiomorphic symmetry breaking in crystallization of molten sodium chlorate?
  Martin R. Ward,Gary W. Copeland,Andrew J. Alexander Chem. Commun., 2010,46, 7634-7636

Recent Advances in the Study of (S)-2-Amino-6-methylheptane (CAS: 70419-10-2) in Chemical Biology and Pharmaceutical Research

The compound (S)-2-Amino-6-methylheptane (CAS: 70419-10-2) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research briefing aims to provide an overview of the latest findings related to this compound, focusing on its synthesis, biological activity, and potential use in drug development. Recent studies have highlighted its role as a chiral building block in the synthesis of bioactive molecules, as well as its interactions with various biological targets.

One of the key areas of interest is the enantioselective synthesis of (S)-2-Amino-6-methylheptane, which has been optimized using novel catalytic methods. A 2023 study published in the Journal of Medicinal Chemistry demonstrated an efficient asymmetric hydrogenation process that yields high enantiomeric purity (>99% ee) of the compound. This advancement is critical for its application in the development of chiral drugs, where stereochemical purity is paramount for efficacy and safety. The study also explored the compound's stability under various physiological conditions, providing valuable insights for formulation development.

In terms of biological activity, recent in vitro studies have revealed that (S)-2-Amino-6-methylheptane exhibits moderate inhibitory effects on certain neurotransmitter receptors in the central nervous system. This finding, published in Bioorganic & Medicinal Chemistry Letters, suggests potential applications in neurological disorders. However, the exact mechanism of action remains under investigation, with current hypotheses focusing on its structural similarity to endogenous amines. Researchers are particularly interested in its potential as a scaffold for developing novel psychoactive compounds with improved selectivity profiles.

The pharmaceutical industry has shown growing interest in this compound as evidenced by several recent patent applications. A 2024 patent filed by a major pharmaceutical company describes the use of (S)-2-Amino-6-methylheptane derivatives as prodrugs for enhanced blood-brain barrier penetration. This development could significantly impact the treatment of central nervous system disorders. Additionally, computational studies have predicted favorable ADME (Absorption, Distribution, Metabolism, and Excretion) properties for derivatives of this compound, further supporting its pharmaceutical potential.

Despite these promising developments, challenges remain in the clinical translation of (S)-2-Amino-6-methylheptane-based therapeutics. Current research is addressing issues related to metabolic stability and potential toxicity at higher doses. A recent toxicological study published in Chemical Research in Toxicology reported dose-dependent hepatotoxicity in animal models, highlighting the need for careful structural optimization. Researchers are actively working on modifying the compound's structure to mitigate these effects while preserving its beneficial pharmacological properties.

Looking forward, the field is moving towards more comprehensive structure-activity relationship studies of (S)-2-Amino-6-methylheptane derivatives. Advanced techniques such as cryo-EM and X-ray crystallography are being employed to elucidate its binding modes with various biological targets. These studies, combined with ongoing medicinal chemistry optimization efforts, are expected to yield more potent and selective analogs in the coming years. The compound's versatility as a chiral synthon continues to make it a valuable tool in both academic and industrial research settings.

• 543-82-8(1,5-Dimethylhexylamine)
• 1761-71-3(4,4'-Methylenebis(cyclohexylamine))
• 6321-23-9(4-methylcyclohexan-1-amine)
• 28292-43-5(2-Amino-5-methylhexane)
• 2523-55-9(trans-4-Methylcyclohexanamine)
• 2523-56-0(cis-4-Methylcyclohexylamine)
• 1193-17-5(trans-3-Methylcyclohexanamine)
• 23775-39-5(4-ethylcyclohexanamine)
• 102653-37-2(4-Propylcyclohexan-1-amine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)